Newsweek article, "The new variant is thought to have 32 mutations in its spike protein, more than double the number of "bad spike mutations" in the Delta variant. The spike proteins on the surface of a virus enable it to attach to and infect human cells, thus allowing the virus to replicate throughout the body."

Does an ACE2 inhibitor assist in reducing OMICRON ability to infect?  Does ABL have that ability to reduce COVID 19’s spread combined with antivirus vaccines?   Appears the COVID 19 test is even more important.  Are we getting too short on time?

Will the next variant have 64 mutations?

If current vaccines hold true to stop Omicron, those unvaccinated are in a terrible position. Strange they do not want the jab, but will gladly take any drug administered by the ICU.

Hopefully this will benefit RVX and dosing will begin.  If ABL is dosed to an Omicron patient and it does not stop the spread, bad news for RVX.

Trend is not good for the 7 Billion on spaceship Earth.   Why the hold on ABL test, it is save! sidebar.